Waters Corporation (WAT):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Waters Corporation (WAT) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7334
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:37
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Waters Corporation (Waters) is an analytical instrument manufacturing company. It carries out the design, production, commercialization and servicing of analytical technologies such as high performance liquid chromatography (HPLC), ultra-performance liquid chromatography (UPLC), chromatography columns and chemistry products, mass spectrometry (MS) systems, thermal analysis, rheometry and calorimetry instruments. The company offers its solutions to pharmaceutical, biochemical, life sciences, industrial, academic and governmental institutions working in the areas of research and development, quality assurance and other laboratory applications Waters distributes its products primarily through its facilities located in Taunton, Massachusetts; Wilmslow, England; and Wexford, Ireland. Waters is headquartered in Milford, Massachusetts, the US.

Waters Corporation (WAT) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Waters Corporation, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Waters Corporation, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Waters Corporation, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Waters Corporation, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Waters Corporation, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Waters Corporation, Medical Equipment, Deal Details 10
Asset Purchase 10
Waters Acquires REIMS Technology from MediMass 10
Partnerships 11
Sotax Enters into Licensing Agreement with Waters 11
Waters Enters Into Co-Development Agreement With Nonlinear Dynamics 12
Waters Enters Into Co-Marketing Agreement With Protea Biosciences Group For LASEI DP-1000 13
Debt Offering 14
Waters Raises USD50 Million in Private Placement of Series I Notes Due 2023 14
Waters Raises USD40 Million in Private Placement of Series J Notes Due 2024 15
Waters Raises USD160 Million in Private Placement of Series K Notes Due 2026 16
Acquisition 17
Waters Acquires Nonlinear Dynamics From The Angel CoFund 17
Waters Acquires Blue Reference, Maker Of Application Scientific Databases, For US$14 Million 18
Waters Corporation – Key Competitors 19
Waters Corporation – Key Employees 20
Waters Corporation – Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21
Recent Developments 23
Financial Announcements 23
Apr 24, 2018: Waters Reports First Quarter 2018 Financial Results 23
Jan 23, 2018: Waters Corporation Reports Fourth Quarter and Full Year 2017 Financial Results 24
Oct 24, 2017: Waters Reports Third Quarter 2017 25
Jul 25, 2017: Waters Reports Second Quarter 2017 Financial Results 26
Apr 25, 2017: Waters Reports First Quarter 2017 Financial Results 27
Jan 24, 2017: Waters Reports Fourth Quarter and Full Year 2016 Financial Results 28
Corporate Communications 29
Sep 04, 2018: Waters names Linda Baddour and Gary Hendrickson as Board Directors 29
Jun 22, 2017: Waters Elects Flemming Ornskov to Board of Directors 30
Product News 31
Jun 08, 2017: Waters UPLC and Mass Spectrometry Systems Approved for In-Vitro Diagnostic use in Brazil 31
Mar 06, 2017: Waters Introduces Cloud Deployable CDS, New Lines of Thermogravimetric Analyzers at Pittcon 2017 32
Feb 27, 2017: Waters Honors Singapore’s Bioprocessing Technology Institute (BTI) for Glycoscience Research 34
Other Significant Developments 35
Sep 19, 2017: Biognosys and Waters Corporation announce a co-marketing agreement at HUPO2017 35
Mar 15, 2017: Waters Now Offers Proteolabels Software 36
Appendix 37
Methodology 37
About GlobalData 37
Contact Us 37
Disclaimer 37

List of Tables
Waters Corporation, Medical Equipment, Key Facts, 2017 2
Waters Corporation, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Waters Corporation, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Waters Corporation, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Waters Corporation, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Waters Corporation, Deals By Market, 2012 to YTD 2018 8
Waters Corporation, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Waters Acquires REIMS Technology from MediMass 10
Sotax Enters into Licensing Agreement with Waters 11
Waters Enters Into Co-Development Agreement With Nonlinear Dynamics 12
Waters Enters Into Co-Marketing Agreement With Protea Biosciences Group For LASEI DP-1000 13
Waters Raises USD50 Million in Private Placement of Series I Notes Due 2023 14
Waters Raises USD40 Million in Private Placement of Series J Notes Due 2024 15
Waters Raises USD160 Million in Private Placement of Series K Notes Due 2026 16
Waters Acquires Nonlinear Dynamics From The Angel CoFund 17
Waters Acquires Blue Reference, Maker Of Application Scientific Databases, For US$14 Million 18
Waters Corporation, Key Competitors 19
Waters Corporation, Key Employees 20
Waters Corporation, Subsidiaries 21

List of Figures
Waters Corporation, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Waters Corporation, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Waters Corporation, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Waters Corporation, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Waters Corporation, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Waters Corporation, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Waters Corporation, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Waters Corporation, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Waters Corporation (WAT):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • U.S. Bancorp:企業のM&A・事業提携・投資動向
    U.S. Bancorp - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's U.S. Bancorp Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …
  • Nacional Financiera S.N.C.:企業の戦略・SWOT・財務情報
    Nacional Financiera S.N.C. - Strategy, SWOT and Corporate Finance Report Summary Nacional Financiera S.N.C. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Tokio Marine Asia Pte. Ltd.
    Tokio Marine Asia Pte. Ltd. - Strategy, SWOT and Corporate Finance Report Summary Tokio Marine Asia Pte. Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Curtiss-Wright Corp (CW):電力:M&Aディール及び事業提携情報
    Summary Curtiss-Wright Corp (Curtiss-Wright) is a manufacturing and service company. It designs, manufactures, and overhauls precision components and provides highly engineered critical function products. The company also provides support services for critical applications. Curtiss-Wright serves cus …
  • Altimmune Inc (ALT):製薬・医療:M&Aディール及び事業提携情報
    Summary Altimmune Inc (Altimmune), formerly Vaxin Inc is an immunotherapeutics company that develops vaccines and other biological products. The company’s products include nasovax, an intranasally administered recombinant influenza vaccine; and heptcell, an immunotherapy for patients chronically inf …
  • First Solar, Inc.:企業のM&A・事業提携・投資動向
    First Solar, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's First Solar, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), div …
  • Laboratory Corporation of America Holdings:企業のM&A・事業提携・投資動向
    Laboratory Corporation of America Holdings - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Laboratory Corporation of America Holdings Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detai …
  • Cleanaway Waste Management Ltd (CWY):企業の財務・戦略的SWOT分析
    Summary Cleanaway Waste Management Ltd (Cleanaway), formerly Transpacific Industries Group Ltd, is a clean technology company that offers waste management and recycling services. The company's services include general waste cleaning and maintenance, industrial cleaning services, liquid and hazardous …
  • The Save Mart Companies:企業の戦略・SWOT・財務情報
    The Save Mart Companies - Strategy, SWOT and Corporate Finance Report Summary The Save Mart Companies - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Hudson Global Inc (HSON):企業の財務・戦略的SWOT分析
    Hudson Global Inc (HSON) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Denso Corporation:企業の戦略・SWOT・財務分析
    Denso Corporation - Strategy, SWOT and Corporate Finance Report Summary Denso Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Columbia University-製薬・医療分野:企業M&A・提携分析
    Summary Columbia University (CU) is an educational service provider that offers educational and research programs. The university provides educational services and courses through its schools, departments, faculties, centers and institutes. It provides undergraduate and graduate courses in various d …
  • Molecular Health GmbH:製薬・医療:M&Aディール及び事業提携情報
    Summary Molecular Health GmbH (Molecular Health) is a biomedical company that designs, develops, manufactures and commercializes software systems which performs integrated analysis of clinical and genomic patient data to support treatment decisions and provide related services. The company offers Mo …
  • Tereos:企業の戦略・SWOT・財務分析
    Tereos - Strategy, SWOT and Corporate Finance Report Summary Tereos - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, prov …
  • Cytokinetics Inc (CYTK)-製薬・医療分野:企業M&A・提携分析
    Summary Cytokinetics Inc (Cytokinetics) is a late stage biopharmaceutical company, which discovers, develops, and commercializes muscle activators for the treatment of diseases, which compromise muscle performance. The company’s lead drug candidate, tirasemtiv, a fast skeletal muscle troponin activa …
  • SANUWAVE Health Inc (SNWV):企業の財務・戦略的SWOT分析
    Summary Sanuwave Health Inc (Sanuwave), formerly Rub Music Enterprises Inc, is a medical device company that develops and commercializes noninvasive biological response activating devices. The company offers products such as dermapace, which is used in the treatment of chronic and acute conditions o …
  • Sonova Holding AG:企業の戦略・SWOT・財務情報
    Sonova Holding AG - Strategy, SWOT and Corporate Finance Report Summary Sonova Holding AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Revance Therapeutics Inc (RVNC):医療機器:M&Aディール及び事業提携情報
    Summary Revance Therapeutics Inc (Revance Therapeutics) develops, manufactures and commercializes novel botulinum toxin products. The company’s product candidate includes RT002, an injectable formulation of botulinum toxin type for the treatment of glabellar lines, cervical dystonia, and plantar fas …
  • Enerjisa Enerji AS (ENJSA):企業の財務・戦略的SWOT分析
    Enerjisa Enerji AS (ENJSA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Genalyte Inc:製品パイプライン分析
    Summary Genalyte Inc (Genalyte) is a healthcare service provider that develops cancer biomarker panels and testing platforms for screening. The company provides technologies such as the Maverick Detection System and Silicon Photonics Biosensor technology. Its Maverick Detection System quantifies the …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆